A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam

Background: COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to treat COVID-19. This clinical trial is designed to evaluate chloroquine as a potential th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kestelyn, Evelyne, Dung, Nguyen Thi Phuong, Lam Minh, Yen, Hung, Le Manh, Quan, Nguyen Minh, Dung, Nguyen Thanh, Minh, Ngo Ngoc Quang, Xuan, Tran Chanh, Phong, Nguyen Thanh, Ninh Thi Thanh, Van, Donovan, Joseph, Tu, Tran Nguyen Hoang, Nhat, Le Thanh Hoang, Truong, Nguyen Thanh, Man, Dinh Nguyen Huy, Thao, Huynh Phuong, Ngoc, Nghiêm My, Lam, Vo Thanh, Phat, Huynh Hong, Phuong, Phan Minh, Geskus, Ronald B., Ha, Vo Thi Nhi, Quang, Nguyen Ngo, Tran Tinh, Hien, Tan, Le Van, Thwaites, Guy E., Day, Jeremy N., Chau, Nguyen Van Vinh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573712/
https://www.ncbi.nlm.nih.gov/pubmed/33110944
http://dx.doi.org/10.12688/wellcomeopenres.15936.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573712/
https://www.ncbi.nlm.nih.gov/pubmed/33110944
http://dx.doi.org/10.12688/wellcomeopenres.15936.1

Ejemplares similares